Seth Klarman
Baupost Group
Baupost Group Portfolio 13F
Seth Klarman Holdings Activity
- Portfolio value:
- $5.95B≈ (+$860M≈)
- Previous value:
- $5.09B≈
- # of changes:
- 12
- New positions:
- 2
- Reported for:
- 31 Mar 2015 (Q1)
- Latest filing date:
- 15 May 2015
Baupost Group has disclosed a total of 12 changes to the portfolio in the (2015 Q1) SEC report(s): increased the number of shares of 8, bought 2 totally new, decreased the number of shares of 1 and completely sold out 1 position(s).
What stocks did Seth Klarman buy in 2015 Q1?
During 2015 Q1 Seth Klarman has bought 10 securities out of which top 5 purchases (by % change to portfolio) were (PXD) Pioneer Natural Resources Co (new buy), (AR) Antero Resources Corp (added shares +19.11%), (KERX) Keryx Biopharmaceuticals Inc (added shares +22.30%), (SEMI) SUNEDISON SEMICONDUCTOR LTD (added shares +90.52%) and (ATRA) Atara Biotherapeutics Inc (added shares +90.84%).
In the 2015 Q1 report(s) the following change has been made to the top investments: (PXD) Pioneer Natural Resources Co (new buy).
12 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
KLX Inc
|
new
|
$38.54
|
|
0.97%
|
2015 Q1
|
≈ 0.25 years
|
||||
|
|
Pioneer Natural Resources Co
|
new
|
$163.51
|
|
8.70%
|
2015 Q1
|
≈ 0.25 years
|
||||
|
|
Atara Biotherapeutics Inc
|
+90.84%
|
$40.48
|
-78.57%($8.67)
|
3.24%
|
2014 Q4
|
≈ 0.50 years
|
||||
|
|
SUNEDISON SEMICONDUCTOR LTD
|
+90.52%
|
$25.82
|
+50.70%($38.91)
|
3.43%
|
2014 Q2
|
≈ 1.00 year
|
||||
|
|
AMERICAN INTERNATIONAL-CW21
|
+41.08%
|
$21.88
|
|
0.46%
|
2013 Q2 or earlier
|
≈ 2.00+ years
|
||||
|
|
Onity Group Inc
|
+31.29%
|
$123.75
|
-69.32%($37.96)
|
1.09%
|
2014 Q3
|
≈ 0.75 years
|
||||
|
|
Keryx Biopharmaceuticals Inc
|
+22.30%
|
$12.73
|
|
4.79%
|
2014 Q1
|
≈ 1.25 years
|
||||
|
|
Bellatrix Exploration Ltd
|
+20.64%
|
$2.43
|
|
0.89%
|
2014 Q4
|
≈ 0.50 years
|
||||
|
|
Antero Resources Corp
|
+19.11%
|
$35.32
|
-1.95%($34.63)
|
5.55%
|
2014 Q3
|
≈ 0.75 years
|
||||
|
|
THERAVANCE BIOPHARMA INC
|
+5.04%
|
$17.35
|
-2.62%($16.90)
|
1.86%
|
2014 Q2
|
≈ 1.00 year
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.